Indications and uses
May temporarily relieve symptoms associated with the flu: • aches • pains.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Influenzinum 200C
- Manufacturer
- Energique, Inc. | Apotheca Company
- Effective date
- 2025-05-16
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-06-01 02:33:35
Label at a glance#
ProductInfluenzinum 200C
Active ingredientINFLUENZA A VIRUS WHOLE, INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) WHOLE, INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE, INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE
Label structure9 sections
Dosage and administration
• Adults and children 5 to 10 drops orally, 1 time daily or as otherwise directed by a health care professional. • Consult a physician for use in children under 12 years of age.
Contacts and useful links#
Label contents#
Full prescribing information#
ACTIVE INGREDIENT:
(in each drop) Influenzinum 200C 100%.
PURPOSES:
Influenzinum 200C - aches and pains.**
**Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
USES:
May temporarily relieve symptoms associated with the flu: • aches • pains.**
**Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
WARNINGS:
Stop use and ask a doctor if symptoms persist for more than 3 days.
If pregnant or breastfeeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
DO NOT USE IF TAMPER EVIDENT SEAL IS BROKEN OR MISSING.
Store in a cool, dry place.
KEEP OUT OF REACH OF CHILDREN:
In case of overdose, get medical help or contact a Poison Control Center right away.
DIRECTIONS:
• Adults and children 5 to 10 drops orally, 1 time daily or as otherwise directed by a health care professional.
• Consult a physician for use in children under 12 years of age.
INACTIVE INGREDIENTS:
Demineralized water, 20% Ethanol.
QUESTIONS:
Dist. by Energique, Inc.
201 Apple Blvd.
Woodbine, IA 51579
800.869.8078
PACKAGE LABEL DISPLAY:
ENERGIQUE
SINCE 1987
HOMEOPATHIC REMEDY
INFLUENZINUM
200C
2023-2024
1 fl. oz. (30 ml)
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 44911-0705-1 | Influenzinum 200C | 30 mL in 1 BOTTLE, DROPPER | LIQUID | 30 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 44911-0705 | INFLUENZINUM 200C (INFLUENZINUM (2023-2024)) LIQUID [ENERGIQUE, INC.] | 3 | Current NDC, 1 package rows | 20250519_f8bb00f6-a6eb-4cff-80e1-aca70196fe10.zip |
Products#
Every source-derived product name is available through these pages.
- Influenzinum 200C
- Influenzinum (2023-2024)
- INFLUENZA A VIRUS WHOLE
- INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) WHOLE
- INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE
- INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE
- WATER
- ALCOHOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 44911-0705 | 44911-0705-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| INFLUENZA A VIRUS WHOLE | R9HH0NDE2E | ACTIB |
| INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) WHOLE | PMY5J4Z7LS | ACTIB |
| INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE | CYK5P89K8X | ACTIB |
| INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE | PS2DCE2WVF | ACTIB |
| WATER | 059QF0KO0R | IACT |
| ALCOHOL | 3K9958V90M | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Influenzinum 200C | INFLUENZINUM (2023-2024) | Energique, Inc. | f8bb00f6-a6eb-4cff-80e1-aca70196fe10 | 2025-05-16 | Warnings | 44911-0705-1 44911-0705 44911070501 6c9ed6b5-b504-44a3-a36a-2fa147e28868 f8bb00f6-a6eb-4cff-80e1-aca70196fe10 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.